-
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages
来源: Buzz FX / 25 2月 2025 02:51:17 America/New_York
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat February 25, 2025 Share Link copied to clipboard. BridgeBio Pharma, Inc. ( NASDAQ:BBIO - Get Free Report ) has receive
Read more...